Home » Topics » Disease categories and therapies » Immune

Immune
RSS

MedImmune responds to FluMist complete response letter

Feb. 12, 2003

Cerus begins phase I trial of EBV vaccine

Feb. 10, 2003

Vical to develop DNA vaccine against CMV

Feb. 10, 2003

Potent, small-molecule IL-2/IL-2Ralpha antagonist designed at Sunesis

Feb. 7, 2003

Grant supports study of HE-2200 for treatment of traumatic shock

Feb. 5, 2003

Antex files initial IND for Tracvax

Feb. 5, 2003

AnorMED files orphan drug application for AMD-3100

Feb. 5, 2003

BioSante signs malaria vaccine CRADA with U.S. Navy

Feb. 3, 2003

Complete response letter issued for MedImmune's intranasal flu vaccine

Jan. 31, 2003

Immunomodulatory effects of WY-14643 demonstrated in mice

Jan. 31, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026